Glucocorticoids in the treatment of croup: barking up the right tree

Klassen, Gerry P.
November 1998
CMAJ: Canadian Medical Association Journal;11/03/98, Vol. 159 Issue 9, p1121
Academic Journal
Editorial. Presents ideas regarding the treatment of croup in young children. Use of glucocorticoids; Details of studies performed on inpatients; Symptoms of croup; Questions which arose during the studies; Outcome. INSETS: Historical debate on the treatment of croup;Treatment recommendations for croup.


Related Articles

  • Nebulized budesonide in children with mild croup.  // American Family Physician;11/15/1994, Vol. 50 Issue 7, p1536 

    Focuses on research conducted by Klassen and colleagues on the benefit of glucocorticoid therapy in children with mild croup from the August 4, 1994 issue of the periodical `New England Journal of Medicine.' Study of 54 children with mild to moderate croup; Findings showing that nebulized...

  • Glucocorticoids for Acute Viral Bronchiolitis in Infants and Young Children. Fernandes, Ricardo M.; Hartling, Lisa // JAMA: Journal of the American Medical Association;1/1/2014, Vol. 311 Issue 1, p87 

    The article discusses the findings of randomized clinical trials which evaluated the use of systemic and inhaled glucocorticoids in infants and young children with acute viral bronchiolitis. It was found that there was no clinically relevant link between single glucocorticoid therapy and reduced...

  • Protecting Bone During Glucocorticoid Treatment. Kuritz, Louis // Internal Medicine Alert;1/29/2008, Vol. 30 Issue 2, p8 

    The article offers guidelines on how patients receiving long term Glucocorticoid treatment can prevent bone loss and reduce the risk of fractures.

  • New indication.  // Geriatrics;Aug99, Vol. 54 Issue 8, p12 

    Reports on the approved additional indication of alendronate sodium or Fosamax, the treatment of glucocorticoid-induced osteoporosis in men and women. Findings of a study conducted on the treatment; Dosage recommendations for the treatment of low bone mass in men and women receiving...

  • Genetics of Glucocorticoids in Asthma.  // New England Journal of Medicine;12/22/2011, Vol. 365 Issue 25, p2434 

    A letter to the editor is presented in response to an article about the significant association between the GLCCI1 variant rs37972 and the response to glucocorticoid therapy in asthma patients by K. G. Tantisira in the September 29, 2011 issue.

  • Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Saag, Kenneth G.; Emkey, Ronald; Schnitzer, Thomas J.; Brown, Jacques P.; Hawkins, Federico; Goemaere, Stefan; Thamsborg, Gorm; Liberman, Uri A.; Delmas, Pierre D.; Malice, Marie-Pierre; Czachur, Michelle; Daifotis, Anastasia G.; Lane, Nancy; Correa-Rotter, Ricardo; Yanover, Melissa; Westhovens, Rene; Epstein, Sol; Adachi, Jonathan D.; Poubelle, Patrice; Melo-Gomes, Jose // New England Journal of Medicine;07/30/98, Vol. 339 Issue 5, p292 

    Background: Osteoporosis is a common complication of long-term glucocorticoid therapy for which there is no well-proved preventive or restorative treatment. Methods: We carried out two 48-week, randomized, placebo-controlled studies of two doses of alendronate in 477 men and women, 17 to 83...

  • Comparison of the Systemic Availability of Fluticasone Propionate in Healthy Volunteers and Patients with Asthma. Daley-Yates, P.T.; Tournant, J.; Kunka, R.L. // Clinical Pharmacokinetics;2000 Supplement, Vol. 39 Issue 6, p39 

    Objectives: The aim of this analysis was to compare the systemic exposure to inhaled fluticasone propionate (FP) after administration of either single or repeated dose regimens via dry powder and metered-dose inhalers in patients with asthma and healthy volunteers. Background: The...

  • From the editors.  // Nature Reviews Neuroscience;Oct2010, Vol. 11 Issue 10, p661 

    An introduction to the journal is presented in which the editors discuss an article concerning the formulation of SNARE hypothesis of intracellular membrane fusion, the therapeutic use of glucocorticoid stress hormones by Lightman and Conway-Campbell, and the role of glucocorticoids in promoting...

  • Treatment and Outcome of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency. Lee, Peter A.; Fuqua, John S.; Nebesio, Todd D. // International Journal of Pediatric Endocrinology;2010, p1 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the diagnosis and treatment of congenital adrenal hyperplasia (CAH), psychological management of CAH, and the use of glucocorticoids as a CAH treatment.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics